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Original Article

Immediate Changes in Hemodynamics and Gas Exchange after Initiation
of Noninvasive Ventilation in Cardiac Surgical Patients
Abstract

Introduction: Cardiac surgery is associated with pulmonary dysfunction and complications such
as prolonged intubation and reintubation. Bilevel positive airway pressure (BiPAP) machine has
been used in the clinical settings to improve oxygenation, reduce work of breathing, and avoid
reintubation. The effect of BiPAP on cardiovascular parameters is not well established, and very
few studies have targeted hemodynamic changes. The aim of the study was to assess the immediate
effect of BiPAP on respiratory and hemodynamic parameters in post‑cardiac surgery patients.
Materials and Methods: This quasi‑experimental study was done on 33 adult cardiac surgery
patients. Ethical review committee approval was sought and consent was taken. All patients
who were in respiratory distress with respiratory rate of >30/min and/or PaO2:FiO2 ratio of <200
were included. Hemodynamic and respiratory parameters were recorded just before and 15 min
after BiPAP application. Sample size was determined on the basis of BiPAP effect on one of the
variables, PaO2:FiO2 ratio. Results: A total of 33 patients were included in the study. The average
age of the patients was 60.97 ± 10.8, of which 23 (69.7%) were males and 10 (30.7%) females.
BiPAP application leads to statistically significant improvement in ventilator parameters including
SaO2 29 (87.7%), PaO2 29 (87.8%), PaCO2 21 (63.6%), and PaO2:FiO2 ratio in 27 (81.8%).
Conclusion: Ventilatory parameters were significantly improved after BiPAP application in this
study, but hemodynamic parameters showed no statistically significant change. BiPAP application
was also able to decrease the need for reintubation in post‑cardiac surgery patients.
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Introduction
Cardiac surgery is associated with
pulmonary dysfunction, which can lead
to postoperative complications such as
prolong intubation, respiratory distress, and
reintubation. The reasons for pulmonary
dysfunction after cardiac surgery includes
general anesthesia, surgery time, mechanical
ventilation, atelectasis, fluid overload,
pleural opening, lung parenchymal injury
due to cardiopulmonary bypass (CPB) and
microembolization, pain due to incision,
chest tubes’ presence, and phrenic nerve
injury. Preservation of pleural integrity is
associated with better respiratory function
and reduced length of stay.[1] Use of left
internal mammary artery in cardiac surgery
is also associated with more respiratory
dysfunction than only saphenous vein
grafts.[2] In addition, preoperative factors
such as preexisting lung diseases, smoking,
old age, and poor nutritional state among
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others are a predisposition to complications.
Respiratory dysfunction in cardiac surgical
patient appears early in the postoperative
period, but these changes are usually
transient and respond to interventions.
Bilevel positive airway pressure (BiPAP)
machine has been used in the clinical
settings for patients with pulmonary
edema,[3] high‑risk postoperative patients,
and acute hypoxemic respiratory failure.
When
compared
with
endotracheal
intubation,[4] the BiPAP is more comfortable,
has a role in avoiding intubations, provides
better outcome (mortality and nosocomial
infection), and helps in avoiding
ventilator‑associated complications such
as ventilator‑associated pneumonia and
need for deep sedation. Other advantages
include improved oxygenation[5,6] and
decreased work of breathing which, in
turn, reduces myocardial oxygen demand.
It recruits atelectatic alveoli and improves
lung compliance. It may also have a role in
reducing the risk of nosocomial infection.
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Studies have shown that intubation and mechanical
ventilation in respiratory compromised patients is
associated with higher mortality,[7] and BiPAP may help in
reducing such complications.[8]

due to drowsiness or respiratory distress, it was taken from
close family members (parents, spouse, and children). This
decision was made after consultation with ethical review
committee.

BiPAP supports respiration during inspiration by applying
inspiratory positive airway pressure (IPAP; which is the
sum of pressure support and PEEP), and during expiration
it acts like positive end‑expiratory pressure by application
of expiratory positive airway pressure (EPAP). It also
increases PaO2:FiO2 ratio. Low ratio in cardiac surgical
patients is associated with higher intensive care unit (ICU)
mortality and pulmonary complications such as atelectasis
and pulmonary edema.[9] BiPAP application improves
atelectasis, and BiPAP has been used in post‑cardiac
surgery patients to avoid intubation. Some patients may
not tolerate the mask and become restless. BiPAP may
not work well in extremely agitated, uncooperative,
and claustrophobic patients. In addition, it may not be
beneficial in hemodynamically unstable patients and those
with excessive airway secretion.

Consecutive cardiac surgical patients who fulfilled BiPAP
application criteria were included in nonrandomized
fashion. Sufficient communication was established with the
patients, so that the procedure is well understood. BiPAP
applied only to those patients who were present in CICU.
Full face mask was used to cover the mouth and nose and
then attached with portable BiPAP machine (VPAP III
STA QuickNav; ResMed, Australia). It delivers a positive
pressure through a single air circuit with the exhaled air
exiting through a mask exhaust vent. Initial settings of IPAP
12 and EPAP of 6 were applied and gradually increased
accordingly. No attempt was made to wean off during
the study period. The patient was monitored for mask
intolerance, gastric distension, and facial skin laceration.

The effect of BiPAP on cardiovascular system is not
very well established, and very few studies have targeted
hemodynamic changes. These changes are more important
for post‑cardiac surgery patients who are not only
recovering from the effect of cardioplegia but also having
variable volume status. This is probably the only study
where all important invasive and noninvasive hemodynamic
parameters are considered along with ventilator parameters.
The aim of the study was to assess the immediate effect
of BiPAP on respiratory and hemodynamic parameters in
those post‑cardiac surgery patients who require noninvasive
ventilation (NIV).

Materials and Methods
This quasi‑experimental study was performed on
33 adult cardiac surgery patients between the ages of
35 and 70 years. Ethical review committee approval
was sought. All patients on respiratory distress were
initially managed by higher FiO2 by mask, respiratory
therapy including nebulization, and prop up position.
Those patients who remained in respiratory distress with
respiratory rate of >30/min and PaO2:FiO2 ratio <200
were included in the study. BiPAP was applied as soon
as the patient met these two criteria. Patient or family
refusal and elective application of BiPAP were taken as
exclusion criteria. Emergency surgery and preexisting
pulmonary dysfunction patients were also excluded. Before
initiating BiPAP, possible surgical complications such as
anastomosis leakage, hemorrhage, pneumothorax, and
cardiac tamponade were excluded. Decision about BiPAP
application was taken by on‑call resident after consultation
with covering consultant of cardiac ICU (CICU). BiPAP
was explained to these patients and consent was taken. For
those patients who were unable to give written consent
60

All data were recorded on a proforma, which included
demographics, reason for application, SaO2 at the time of
first application, time it started, total duration of application,
initial settings, range (minimum and maximum), and
outcome of BiPAP application. These data were collected
by residents and consultants who were involved in patient
management.
Sample size was based on the study by Takami and Ina[10]
and determined on the basis of the effect on one of the
variables, PaO2:FiO2 ratio. Changes in the hemodynamic,
BiPAP parameters, SaO2, PaO2, PaCO2, heart rate (HR),
mean blood pressure (BP), central venous pressure (CVP),
pulmonary artery (PA) pressure, systemic vascular
resistance (SVR), and pulmonary vascular resistance (PVR)
were calculated from relative changes from the baseline.
A sample size of 33 achieved 90% power to detect a 20%
and above mean paired difference with estimated standard
deviation of the difference being 20, with a significance
level (alpha) of 0.01 using a paired t‑test.
All statistical analysis was performed using Statistical
Package for the Social Sciences version 19 (SPSS Inc.,
Chicago, IL, USA). Frequency and percentage were
computed for categorical observation, while mean and
standard deviation were estimated for numeric variables.
Pre‑ and post‑BiPaP effects on dependent variables were
analyzed by paired t‑test. Repeated measure analysis of
variance test was applied to observe the effect of other
variables on dependent variables. A P value of less than
0.05 was considered as statistically significant.

Results
A total of 33 patients were included in the study.
The average age of the patients was 60.97 ± 10.8, of
which 23 (69.7%) were males and 10 (30.7%) females
[Table 1]. The most common reason for BiPAP application
was atelectasis (51.5%). Diagnosis was left at the discretion
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of CICU intensivist on the basis of X‑ray findings’
interpretation. Patients with pneumonia and obesity
frequently required noninvasive ventilatory support. BiPAP
application lead to statistically significant improvement
in the following parameters: SaO2 29 (87.7%),
PaO2 29 (87.8%), PaCO2 9 (27.3%), and PaO2:FiO2
ratio in 27 (81.8%). Only four patients in our study had
PaO2:FiO2 ratio greater than 150, and of these only one
patient did not show improvement in the ratio after BiPAP
application [Table 2]. Only two patients required escalation
of support during the study period.
Eight patients had body mass index (BMI) greater than 30.
All (n = 3) patients with BMI >35 showed improvement in
SaO2, PaO2, and PaO2:FiO2 ratio after BiPAP application.
Nine of 17 patients who were in respiratory distress due
to atelectasis needed BiPAP application for less than 24 h.
BiPAP was applied preemptively on three patients soon
after extubation due to low PaO2:FiO2 ratio on ventilator.
HR reduced from mean 102 to 92 beats/min, while the
mean BP was increased [Table 3]. Cardiac output which
was measured after 15 min of BiPAP application also
reduced from mean 4.45 ± 1.23 to 4.50 ± 1.34 L/min with
a P value of 0.873.
Thirteen (36.4%) patients required BiPAP support for less
than 24 h. Only one patient required reintubation in the first
24 h, and overall 6 (18.2%) patients ultimately required
reintubation after prolonged BiPAP application [Table 4].
Three patients required reapplication of BiPAP within 24
h after planned removal. Four of five patients who had low
PaO2 on ventilator required BiPAP for more than 24 h.

Discussion
Application of alternating IPAP and EPAP improves
gas exchange by recruiting atelectatic alveoli. IPAP
has an additional advantage of reducing the work of
breathing. In other studies, respiratory parameters were
improved in 30 min, while in this study NIV has shown
improvement within 15 min of application. Zoremba
et al.[11] in their study noticed that the short‑term use
of BiPAP can improve pulmonary function for 24 h.
It decreases the need for sedation, and the patient can
protect his own airway to protect against aspiration. It
also decreases nosocomial infection rate when compared
with reintubation. Diaphragmatic paralysis or dysfunction,
which is not uncommon in cardiac surgical patients,
can be an indication for BiPAP application.[12] The other
advantage includes reduced inotrope requirements and
respiratory infection.[13]
Early application may have a role in reducing
mortality.[14] BiPAP also has a role in reducing the need
for reintubation,[15] particularly in respiratory failure
patients[3] and in cardiogenic pulmonary edema[6] but
does not reduce the incidence of myocardial infarction
and mortality.[16] A meta‑analysis by Bajaj et al.[17] also

Table 1: Demographic, Comorbid and Surgery
status (n=33)

Point estimation
Variables
Age (Years)
60.97±10.81
Weight (kg)
75.90±17.22
Height (cm)
163.07±6.74
Body mass index (kg/m)
28.36±5.56
Gender
Male
24 (72.7%)
Female
9 (27.3%)
Comorbid
Hypertension
27 (81.8%)
Diabetic Mellitus
18 (54.5%)
IHD
7 (21.2%)
Other*
4 (12.1%)
Surgery
CABG
28 (84.8%)
MVR
4 (12.1%)
Pericardiectomy
1 (3%)
Results are presented as mean±SD and n (%), Others*: CKD 2,
obesity 1, AKI 1

Table 2: Reasons, Improvement and total duration of
BiPAP in cardiac surgery patients (n=33)

Variables
n
%
Reason for BiPAP Application
Pneumonia
5
15.2%
Sepsis
2
6.1%
Muscle Weakness
4
12.1%
Obesity
4
12.1%
Low PaO2 ventilator
4
12.1%
COPD
1
3%
Pulmonary edema
1
3%
Respiratory distress due to unknown reason
2
6.1%
Respiratory distress due to atelectasis
17 51.5%
Single Reason
7
21.2%
Multiple Reasons
26 78.8%
Improvement seen in following parameters soon (15 min) after
BiPAP Application
SaO2
25 75.8%
PaO2
23 69.7%
PaCO2
9
27.3%
Clinical Mentation, Drowsiness
7
21.2%
Reduction in respiratory rate after first app BiPAP 12 36.4%
PaO2/FiO2 ratio
27 81.8%
Total Duration of BiPAP
<24 h
12 36.4%
2-3 days
19 57.6%
3-5 or above
2
6.1%
Results are presented as n (%)

concluded that NIV reduces reintubation (10.8% in NIV
vs. 17.8% in conventional group) in chronic obstructive
pulmonary disease and high risk for extubation failure
patients.
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Table 3: Effect of BIPAP application on hemodynamics and ventilator parameters

n
Pre BiPAP
Gas exchange parameters
SaO2
33
90[88.4, 94]
PaO2
33
60.2[55.7,70]
PaCO2
33
44[39.05,51]
PaO2/FiO2 ratio
33
107[94,137]
Base excess
21
0.20[‑0.21, 1.85]
Hemodynamic parameters
HR
33
102[91,111]
Systolic BP
33
112[104.5,128.5]
Diastolic BP
33
63[59,83.5]
Mean BP
33
79.5[70,89]
CVP
32
8.5[7,10]
PA pressure (Systolic)
20
32[25,37.5]
PA pressure (Diastolic)
20
15[13,18]
SVR
20
1259[1003,1712]
CO
14
4.45[2.60,6.25]
Results are presented as median [25th, 75th percentile], Wilcoxon Signed Ranks Test

Outcome of BiPAP Application
Re‑intubation
Day 1

Post BiPAP

P

95[91,97.7]
69[63.6,98.1]
40.5[37.1,45.6]
115[103.5,173]
0.30[‑2.3,2.05]

0.003
0.0005
0.005
0.001
0.259

92[89,108.5]
112[105,125.5]
69[59,83]
84.5[71,90.7]
9[7,11]
28[26,38]
16[14,18]
1264 [999.25,1553]
4.50[2.51,6.54]

0.18
0.443
0.702
0.142
0.062
0.887
0.060
0.959
0.873

Table 4: Outcome of BiPAP Application (n=33)

Number of Patients
6
1

Day 2

2

Day 3

2

Day 4
Able to maintain SaO2 without BiPAP for 24 h
BiPAP reapplication within 24 hrs. of removal
Rate patient’s cooperation after BiPAP application
Fully Cooperative
Reluctant to Cooperate
Non Cooperate

Percentage
18.2%

1
22
3

66.7%
9.1%

30
2
1

90.90%
6.1%
3%

It may also reduce intubation rate in acute respiratory
failure.[18] It reduces the reintubation rate in patients who
are at high risk for postoperative pulmonary complications
or have ongoing acute respiratory failure.[19] Prophylactic
application is ineffective in low‑risk patients, but in
high‑risk patient even few hours of application[20] reduces
reintubation rate. Preemptive BiPAP application was
applied in three patients in our study, and not only it
improved oxygenation but also it prevented reintubation.
BiPAP also has a role in reducing intubation rate in acute
and chronic congestive heart failure (CHF) patients.[21]

be suggested not to use BiPAP in this patient population
due to higher failure rate, and conventional endotracheal
intubation must be preferred.[23] Age of the patients seems
to have no effect on failure rate in this study.

BiPAP has a failure rate of 10%–55%, and the main reason
is pneumonia and older age group.[22] There are various
definitions of failure. For study purpose, we considered
reintubation within 4 days of application as BiPAP failure
and 18% patients needed reintubation in this study. Five
patients in our study also had pneumonia for which BiPAP
was applied. Only two patients required reintubation on day
2 of application, which showed some success, but larger
studies are needed to conclude in these patients. It may

It usually increases SaO2 without significant changes
in PaCO2[24] in normal patients. But in patients with
hypercapnia, its role is different. In our study, BiPAP
application significantly reduces PaCO2 in 21 (63%)
patients. BiPAP seems to be more efficient in patients
with hypercapnia as we have seen in our study that most
of the patients (11 of 14) whose PaCO2 was higher than
45 mmHg showed reduction in PaCO2 within 15 min of
BiPAP application. Our results are similar to other studies
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There was a statistically significant improvement in PaO2
within 15 min of application. It was more effective in 93%
of patients in whom PaO2 was lower than 60 mmHg (14/15).
BiPAP improves oxygenation more rapidly than continuous
positive airway pressure in cardiogenic pulmonary edema
patients.[3]

Annals of Cardiac Anaesthesia | Volume 23 | Issue 1 | January‑March 2020

[Downloaded free from http://www.annals.in on Friday, April 9, 2021, IP: 221.132.113.70]
Hamid, et al.: BiPAP‑related changes in hemodynamic and gas exchange

carried out earlier, which also showed a significant effect of
BiPAP only in patients with hypercapnia.[6,25] Mehta et al.
showed improvement in PaCO2 after BiPAP application,
but it increases acute myocardial infarction rate (71%).[26]
Tobias[5] also demonstrated reduction in respiratory rate
and PaCO2 in postoperative patients. Those patients
were in impending respiratory failure, and application of
BiPAP improved oxygenation and CO2 levels and avoided
reintubation.
We took PaO2:FiO2 ratio of <200 as an inclusion criteria,
and BiPAP application did improve the ratio significantly.
The average value of ratio before and after application
was 107 versus 115. This increase in ratio reached more
than 200 only in five (15.1%) patients. The reason may be
that most of our patients (n = 29) had less than 150 ratio
before BiPAP application. One of the study also used this
ratio for indication[10] and the ratio increased significantly
within 3 min. Park et al.[6] also showed improvement in the
ratio within 10 min of application and required more than
30 min to reach 200 level but those were pulmonary edema
patients.
Hemodynamic effects are varied according to the disease
state and also on the IPAP and EPAP settings and the type
of mask (nasal vs. face). In normal patients, it may decrease
CO, while in chronic heart failure patients it may improve
CO by reducing SVR[27] and preload. Cardiac function
improved in distended heart but not in normal functioning
heart. No significant hemodynamic changes were seen
after BiPAP application during the initial 15 min. It may
be inferred that it needed more time for hemodynamic
improvement or it may be more effective in pulmonary
edema cases as studies have shown a reduction in HR and
SVR after BiPAP application in pulmonary edema patients.
BiPAP reduces sympathetic activity,[28] preload, and
afterload leading to enhanced ventricular function. Mean
arterial pressure (MAP), CVP, and PA diastolic pressures
slightly increase probably due to an increase in intrathoracic
pressure exerted by BiPAP.[29] Insignificant reduction in
HR and PA systolic pressure was seen in our patients.
Decrease in HR occurs due to parasympathetic stimulation
by stretched receptors in lungs. This is in contrast to a
previous study in post‑cardiac surgery patients by Kilic
et al. which showed a slight increase in HR at 1 h along
with a decrease in MAP. These values remain insignificant
even after 12 h of BiPAP application. Cardiac surgery
patients are usually in various stages of hemodynamic
status; some may be hypovolemic or hypervolumic,
while others may still be recovering from the effect of
cardioplegia. In addition, hemodynamics are also affected
by postoperative cardiac index, pain, BiPAP settings, and
patient’s cooperation. Significant HR reduction was seen in
two previous studies, but those were with patients CHF and
the improvement was seen after 30 min.[26,30] This change
in HR in patients with pulmonary edema was significant
within 10 min of application in a study by Marcelo et al.

Although CO was increased in our patients, it was
insignificant. The increase in CO and MAP was probably due
to reduction in preload and improved cardiac contractility
after BiPAP. Another study which is comparable to this
study showed improvement in cardiac index(CI) without
changes in systemic and PA pressures.[15] Atelectasis and
overinflation of lung above functional residual capacity
(FRC) can increase PVR. Takami and Ina showed higher
systemic vascular resistance index and pulmonary arterial
resistance index along with low CI in those patients who
required BiPAP when compared with non‑BiPAP patients.
It will be interesting to see the changes in ionotropes
and vasopressors’ requirement in future studies. Another
limitation relates to heterogeneity of the study subset
unknown baseline respiratory function (we try to exclude
these patients), different types of surgical procedures, CPB
time, and length of postoperative ventilation. Although the
most common mode for weaning at our institute is SIMV, it
would have been ideal to standardize the weaning mode in
all study patients.
Hypoxemia, atelectasis, and respiratory impairment are
more common in obese cardiac surgery patients, and
short‑term use of BiPAP was able to improve pulmonary
functions which lasted for about 24 h after discontinuation.
It is recommended to commence BiPAP early to achieve
maximum benefits. This study also showed improvement in
respiratory parameters in obese patients,[22] particularly in
patients with BMI greater than 35. There is a suggestion
to apply BiPAP, soon after extubation in all patients with
higher BMI. Prophylactic BiPAP also has a role in patients
with low ejection fraction where it reduces the incidence
of atelectasis and at the same time increase PaO2.[31] BiPAP
can be used as a part of fast‑track extubation. As a weaning
mode, it reduces extubation time when compared with
intermittent mandatory ventilation.[32]

Conclusion
Saturation, PaO2, PaCO2, and PaO2:FiO2 ratios were
significantly improved soon after BiPAP application in this
study, but no statistically significant changes were seen in
hemodynamic parameters. BiPAP application was also able
to reduce the need for reintubation in post‑cardiac surgery
patients.
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